Chemical Compound

ginsenoside Rk1

CAS Registry Number 494753-69-4
ginsenoside Rk1 chemical structure
Primary Record

ginsenoside Rk1

Note: Only for scientific research or as raw materials for production.

In stock
8,640 g
Purity
98.9 %
CAS
494753-69-4

Compound Identifiers & Properties

CAS
494753-69-4
PubChem CID
11499198
SMILES
CC(=CCCC(=C)[C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)O)C)C
Canonical SMILES
C=C(CCC=C(C)C)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C

Names & Synonyms

  • ginsenoside Rk1
  • Ginsenoside Rk2
  • Ginsenoside Rk
  • GinsenosideRk1
  • Gisenoside Rk1
  • 494753-69-4
  • RefChem:639975
  • Ginsenoside Rk1 (Standard)
  • CHEMBL251235
  • orb1302317
  • SCHEMBL20904220
  • HY-N2515R
  • Ginsenoside Rk1 (Rk1:Rz1=5:2)
  • WLZ4675
  • C42H70O12
  • DTXSID901354827
  • HY-N2515
  • MSK40338
  • 8136AH
  • s9210
  • ZINC95607708
  • AKOS030530159
  • ACN-047001
  • CCG-270453
  • OG31930
  • CID11499198
  • AC-34688
  • CID 11499198
  • CID:11499198
  • MS-31383
  • XG183076
  • SID:134223636
  • CS-0022786
  • FT-0701284
  • FT-0777161
  • 1,8-DIAZA-2,9-DIKETOCYCLOTETRADECANE
  • J1.672.348G
  • A934975
  • C472077
  • b-D-Glucopyranoside, (3b,12b)-12-hydroxydammara-20,24-dien-3-yl2-O-b-D-glucopyranosyl-
  • (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-(6-methylhepta-1,5-dien-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
  • Ginsenoside Rk1 - Ginsenoside Rk1:Ginsenoside Rz1 (5:2)
  • 3,12-dihydroxydammar-20(21),24-diene-3-O--D-glucopyranosyl(1->2)--D-glucopyranoside
  • 3beta,6alpha,12beta-trihydroxydammar-20(21),24-diene-6-O-beta-D-glucopyranoside
  • (2S,3R,4S,5S,6R)-2-(((2R,3R,4S,5S,6R)-4,5-Dihydroxy-2-(((3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-(6-methylhepta-1,5-dien-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
  • (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-(5-methyl-1-methylene-hex-4-enyl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]tetrahydropyran-3-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
  • (2S,3R,4S,5S,6R)-2-{[(2R,3R,4S,5S,6R)-2-{[(1S,3AR,3BR,5AR,7S,9AR,9BR,11R,11AR)-11-HYDROXY-3A,3B,6,6,9A-PENTAMETHYL-1-(6-METHYLHEPTA-1,5-DIEN-2-YL)-DODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-7-YL]OXY}-4,5-DIHYDROXY-6-(HYDROXYMETHYL)OXAN-3-YL]OXY}-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL
  • (2S,3R,4S,5S,6R)-2-{[(2R,3R,4S,5S,6R)-2-{[(1S,3aR,3bR,5aR,7S,9aR,9bR,11R,11aR)-11-hydroxy-3a,3b,6,6,9a-pentamethyl-1-(6-methylhepta-1,5-dien-2-yl)-hexadecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
  • (3beta, 12beta)-12-Hydroxydammara-20,24-dien-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
  • 1,8-Diaza-2,9-dioxocyclotetradecane; 1,8-Diazacyclopentadecane-2,9-dione; Hexahydro-2H-azepin-2-one Cyclic Dimer; 6-Aminohexanoate Cyclic Dimer; Caprolactam Cyclic Dimer;; Caprolactam Dimer; Cyclic Dimer of e-Caprolactam; 6-Aminohexanoic Acid Bimol. Cyclic Lactam; e-Aminocaproic Acid Cyclic Dimer; e-Caprolactam Cyclic Dimer;
  • 109-890-6
  • 12beta-Hydroxy-5alpha-dammara-20,24-diene-3beta-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
  • 3beta-[(2-O-beta-D-Glucopyranosyl-beta-D-glucopyranosyl)oxy]dammarane-20,24-diene-12beta-ol
  • 3beta-[2-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyloxy]-12beta-hydroxydammara-20,24-diene
  • 56403-09-9
  • Ginsenoside Rk1(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-(6-methylhepta-1,5-dien-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; Gisenoside Rk1